2017 ASCO Annual Meeting

Olivier Tredan, MD, PhD, Département d'Oncologie Médicale, Centre Léon Bérard, presenting Abstract LBA100, Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfilER Study, during Saturday Press Briefing

Chicago, IL - 2017 ASCO Annual Meeting - Olivier Tredan, MD, PhD, Département d'Oncologie Médicale, Centre Léon Bérard, presenting Abstract LBA100, Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfilER Study, during Saturday Press Briefing at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Saturday, June 3, 2017. Approximately 40,000 physicians, researchers, and healthcare professionals from over 100 countries are attending the 53rd Annual Meeting, which is being held at McCormick Place. The ASCO Annual Meeting highlights the latest findings in all major areas of oncology, from basic to clinical and epidemiological studies. Photo by © ASCO/Brian Powers 2017 Technical Questions: todd@medmeetingimages.com; ASCO Contact: photos@asco.org